Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins.
Adoptive transfer of specifically sensitized lymphoid cells constitutes a potential tool for specific cancer immunotherapy, however, the requirement of syngeneic or autologous specifically reactive cells has limited its use in the treatment of human cancer. In several mouse tumor models, large amoun...
Main Authors: | Zanovello, P, Rosato, A, Bronte, V, Cerundolo, V, Collavo, D |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
1991
|
Registos relacionados
-
Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity.
Por: Zanovello, P, et al.
Publicado em: (1989) -
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases.
Por: Zanovello, P, et al.
Publicado em: (1992) -
Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
Por: Ronchese, F, et al.
Publicado em: (1985) -
Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleens of cyclophosphamide-treated mice.
Por: Collavo, D, et al.
Publicado em: (1984) -
Generation and enrichment of antigen-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
Por: Oelke, M, et al.
Publicado em: (2000)